CADNFCascades Inc.
The Read
7% decline after Q1 2026 sales fell despite stable EPS, then a 10.
The schedule
- Thu15Oct
Crucial update on corporate debt structuring and interest coverage ratios.
- Fri15Jan
Market digestion of finalized recycling mandates and sustainable packaging compliance laws.
- Sat6Feb
Q3 results featuring guidance for the structurally important holiday packaging season.
- Sat8May
Full-year results accompanied by initial guidance targets for fiscal 2027.
- Mon10May
First-quarter earnings update testing the company's progress against 2027 targets.
Past
- Wed30Sep
Update on the company's major capital expenditure plans and ongoing mill upgrade projects.
- Sat8Aug
Actual outcome: Bull · $12.21 at outcome
Cascades reported Q2 EPS of $0.39, meeting estimates, but management noted that overall results exceeded expectations. The stock surged well past the bull target as stronger operational execution, higher volumes, and successful commercial initiatives across its packaging and tissue businesses validated the company's pricing and cost controls.
Quarterly earnings report evaluating recent cost-control measures and pricing power.
- Wed1Jul
Actual outcome: Bull · $8.41 at outcome
The mid-2026 North American pricing resets for containerboard and boxboard were successfully implemented, with price increases holding firm across the industry. Stronger-than-expected retail demand allowed these adjustments to stick without sacrificing volume, alleviating margin pressures and driving the stock well past the $8.15 bull target.
Market evaluation of North American pricing adjustments for containerboard and boxboard amid shifting retail demand.
- Sat9May
Actual outcome: Bear · $7.54 at outcome
Cascades reported Q1 2026 results with EPS meeting estimates exactly at $0.39, but sales of $1,125 million represented both a sequential and year-over-year decline. The top-line contraction weighed on investor sentiment, driving the stock down 5.3% toward the bear floor as concerns over volume and pricing overshadowed a slight sequential improvement in operating income.
Q1 2026 results and management’s full-year 2026 outlook will update the market on whether the margin recovery seen into late 2025 can continue, with $8.08 as the starting point and a potential range toward $8.80 on a clean beat/constructive guidance or down to $7.40 if volumes and pricing disappoint.